MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202611060105 A) filed by Noida Institute Of Engineering Technology Pharmacy Institute on May 12, 2026, for A Pharmaceutical Composition For Controlled Enzyme Inhibition.
Inventors include Dr. Anjna Rani; and Dr. Swarupanjali Padhi.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: A pharmaceutical composition for controlled enzyme inhibition comprises an inhibitor containing core, a protective carrier phase, a release rate controlling phase, and a modulation phase arranged to regulate local availability of an enzyme inhibiting active ingredient. The composition stabilizes the inhibitor, limits prematur...